(NASDAQ: MDWD) Mediwound's forecast annual revenue growth rate of 42.33% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 118.19%, and while it is forecast to beat the US market's average forecast revenue growth rate of 23.42%.
Mediwound's revenue in 2026 is $20,932,000.On average, 8 Wall Street analysts forecast MDWD's revenue for 2026 to be $342,755,368, with the lowest MDWD revenue forecast at $308,752,928, and the highest MDWD revenue forecast at $403,875,140. On average, 7 Wall Street analysts forecast MDWD's revenue for 2027 to be $433,390,078, with the lowest MDWD revenue forecast at $395,797,637, and the highest MDWD revenue forecast at $460,353,552.
In 2028, MDWD is forecast to generate $845,624,792 in revenue, with the lowest revenue forecast at $603,120,208 and the highest revenue forecast at $1,274,347,869.